Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT01925612. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Mature B-Cell Lymphoma And Leukemia Study III
ClinicalTrials.gov study NCT01046825. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00101010. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03939182. IPD Sharing: YES. Countries: 1. Publications: 0.
MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma
ClinicalTrials.gov study NCT01415765. IPD Sharing: Not stated. Countries: 0. Publications: 3.
A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell
ClinicalTrials.gov study NCT05121103. IPD Sharing: NO. Countries: 1. Publications: 0.
Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00695409. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL
ClinicalTrials.gov study NCT03571568. IPD Sharing: YES. Countries: 6. Publications: 0.
High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma
ClinicalTrials.gov study NCT01434472. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04767698. IPD Sharing: NO. Countries: 1. Publications: 0.
1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation
ClinicalTrials.gov study NCT03133221. IPD Sharing: NO. Countries: 1. Publications: 0.
Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL
ClinicalTrials.gov study NCT04524455. IPD Sharing: YES. Countries: 9. Publications: 0.
Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma
ClinicalTrials.gov study NCT02541565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00736450. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT04358458. IPD Sharing: NO. Countries: 5. Publications: 0.
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
ClinicalTrials.gov study NCT06634589. IPD Sharing: YES. Countries: 7. Publications: 0.
Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00073749. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial
ClinicalTrials.gov study NCT00911183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
ClinicalTrials.gov study NCT00931918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494
ClinicalTrials.gov study NCT00898157. IPD Sharing: Not stated. Countries: 0. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.